Profile data is unavailable for this security.
About the company
PT Phapros Tbk is an Indonesia-based pharmaceutical company. The Company's business pillars consist of branded/ethical prescription medicines: hospitals and pharmacies in addition to other healthcare institutions; over the counter (OTC) drugs: pharmacies, retail; generic prescription drugs: government institutions and hospitals; toll-in manufacturing, and medical device. The Company has produced approximately 250 types of drugs, which are self-developed and classified into Ethical, OTC, and Generic Drug product groups. The Company's medical devices include ACS MB Primary, ACS FB and FB PS, Primary Hip Stem, INASHUNT Semilunar Flushing, BoneFill Ortho, and NPC-STRIP G. Its branded drugs include Colcatriol 0.25 mcg 30 Cap, Diafac XR, Spirolactone 25 & 1, Dextamine Syrup, Diapros Tablet, Proinfarction, Cardismo Tablet, God, and others. The Company also operates calibration laboratory. The Company’s subsidiaries are PT Lucas Djaja and PT Marin Liza Farmasi.
- Revenue in IDR (TTM)806.40bn
- Net income in IDR-46.65bn
- Incorporated--
- Employees1.38k
- LocationPhapros Tbk PTLantai Dasar, Gedung RNIJl. Denpasar Raya Kav. DIIIKuninganJAKARTA SELATAN 12950IndonesiaIDN
- Phone+62 215762709
- Fax+62 215763910
- Websitehttps://www.phapros.co.id/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BLIS Technologies Ltd | 106.90bn | 5.99bn | 225.43bn | 10.00 | 32.20 | 2.12 | 20.70 | 2.11 | 0.0006 | 0.0006 | 0.0091 | 0.009 | 0.8955 | -- | 8.41 | -- | 5.02 | -2.45 | 5.64 | -2.90 | -- | -- | 5.60 | -2.40 | 8.30 | 23.45 | 0.0328 | -- | 12.61 | 6.52 | 147.85 | 11.14 | 34.35 | -- |
| Can Fite Biopharma Ltd | 10.57bn | -116.75bn | 233.59bn | 5.00 | -- | 4.87 | -- | 22.11 | -0.0176 | -0.0176 | 0.0017 | 0.0055 | 0.0787 | -- | -- | 498,409.10 | -86.95 | -102.29 | -115.77 | -131.07 | -- | -- | -1,105.10 | -1,105.36 | -- | -- | 0.00 | -- | -8.27 | -27.92 | 24.96 | -- | -42.92 | -- |
| Nyrada Inc | 34.82bn | -14.24bn | 235.94bn | -- | -- | 3.97 | -- | 6.78 | -0.0081 | -0.0081 | 0.0209 | 0.0277 | 0.6147 | -- | -- | -- | -25.13 | -53.28 | -29.75 | -62.52 | -- | -- | -40.89 | -236.15 | -- | -- | 0.00 | -- | 115.55 | 46.42 | 82.12 | -- | -- | -- |
| SMAIO SA | 82.01bn | -29.95bn | 236.58bn | 43.00 | -- | 1.76 | -- | 2.88 | -0.3383 | -0.3383 | 0.929 | 1.54 | 0.3738 | 0.3816 | 9.41 | 132,756.80 | -13.65 | -7.87 | -15.68 | -18.43 | 88.45 | 96.04 | -36.52 | -22.48 | 4.25 | -- | 0.236 | -- | 212.18 | 114.99 | -62.80 | -- | -- | -- |
| Extrawell Pharmaceutical Holdings Ltd | 120.41bn | -332.01bn | 238.61bn | 159.00 | -- | 0.1052 | -- | 1.98 | -0.0682 | -0.0682 | 0.0247 | 0.4657 | 0.0433 | 5.90 | 11.81 | 371,685.50 | -11.83 | 1.01 | -12.32 | 1.06 | 48.70 | 50.54 | -273.51 | 18.00 | 3.31 | -0.0753 | 0.0977 | 0.00 | -18.57 | -7.91 | -226.06 | -- | -3.20 | -- |
| IX Biopharma Ltd | 70.18bn | -127.13bn | 239.28bn | 56.00 | -- | 4.07 | -- | 3.41 | -0.014 | -0.014 | 0.0078 | 0.0057 | 0.3013 | 4.20 | 1.99 | -- | -54.58 | -39.79 | -86.37 | -52.71 | 17.59 | 50.67 | -181.14 | -150.87 | 0.7053 | -2.42 | 0.5451 | -- | 0.778 | 54.77 | -12.26 | -- | -29.94 | -- |
| Lasa Supergenerics Ltd | 196.37bn | -36.63bn | 242.16bn | 77.00 | -- | -- | -- | 1.23 | -3.92 | -3.92 | 20.94 | -- | -- | -- | -- | 13,586,300.00 | -- | -3.86 | -- | -5.34 | 26.41 | 32.53 | -18.65 | -5.30 | -- | -4.49 | -- | -- | -19.47 | -9.26 | 43.73 | -- | -- | -- |
| Gelteq Ltd | 0.00 | -24.20bn | 242.42bn | -- | -- | 1.09 | -- | -- | -0.1597 | -0.1597 | 0.00 | 1.49 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 1.38 | -32.41 | 0.0605 | -- | -- | -- | -72.77 | -- | -- | -- |
| Phapros Tbk PT | 806.40bn | -46.65bn | 245.28bn | 1.38k | -- | 0.3573 | 259.50 | 0.3042 | -55.54 | -55.54 | 960.00 | 817.32 | 0.4587 | 1.44 | 1.51 | 547,082,300.00 | -2.69 | 2.07 | -4.42 | 4.04 | 48.90 | 51.79 | -5.86 | 3.68 | 1.10 | 0.0247 | 0.5173 | -- | -13.21 | -0.1734 | -78.77 | -46.21 | -24.81 | -- |
